Welcome to LookChem.com Sign In|Join Free

CAS

  • or

563-63-3

Post Buying Request

563-63-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

563-63-3 Usage

Chemical Description

Silver acetate is a chemical compound with the formula AgC2H3O2.

Description

Different sources of media describe the Description of 563-63-3 differently. You can refer to the following data:
1. Silver acetate (C2H3AgO2) is a photosensitive, white, crystalline solid which is widely used in the laboratory. As a source of silver ions lacking an oxidizing anion, it is a useful reagent for direct ortho-arylation, and for conversion of organohalogen compounds into alcohols, etc. It also serves as a catalyst to effectively catalyze the cycloaddition reactions of isocyanoacetates with a variety of olefins. It can be employed in the novel preparation of highly reflective, conductive silvered polymer films.Besides, it has applications in some antismoking drugs and in the health field, in which the products containing silver acetate have been applied in spray, and lozenges to deter smokers from smoking. When mixed with smoke, the silver acetate creates an unpleasant metallic taste in the smoker's mouth, thereby preventing them from smoking.
2. Silver acetate is an organic compound with the empirical formula CH3COOAg (or AgC2H3O2). It is a photosensitive, white crystalline solid. It is a useful reagent in the laboratory as a water soluble source of silver lacking an oxidizing anion. It has been used in some antismoking drugs.

References

https://en.wikipedia.org/wiki/Silver_acetate https://www.alfa.com/zh-cn/catalog/011660/ http://www.sigmaaldrich.com/catalog/product/sigma/s1633?lang=en®ion=US

Chemical Properties

Off-White/Brown Crystalline Powder

Uses

Different sources of media describe the Uses of 563-63-3 differently. You can refer to the following data:
1. Oxidizing agent for use in liquid ammonia: Kline, Kershner, Inorg. Chem. 5, 932 (1966).
2. In the health field, silver acetate-containing products have been used in gum, spray, and lozenges to deter smokers from smoking. The silver in these products, when mixed with smoke, creates an unpleasant metallic taste in the smoker's mouth, thus deterring them from smoking. Lozenges containing 2.5 mg of silver acetate showed "modest efficacy" on 500 adult smokers tested over a three-month period. However, over a period of 12 months, prevention failed. In 1974, silver acetate was first introduced in Europe as an over-thecounter smoking-deterrent lozenge (Repaton) and then three years later as a chewing gum (Tabmint).
3. It is a reagent in the laboratory as a source of silver ions lacking an oxidizing anion. It is a reagent for direct ortho-arylation, and for conversion of organohalogen compounds into alcohols. Woodward cis-hydroxylation reaction employs silver acetate and iodine for selective conversin of alkenes into cis-diols. Silver acetate is the more preferred reagent for facile carbonylation of primary and secondary amines. It is also employed in the preparation of highly reflective, conductive silvered polymer films.

Reactions

3 – 1 - Carbonylation Silver acetate, when combined with carbon monoxide (CO), can induce the carbonylation of primary and secondary amines. Other silver salts can be used but the acetate gives the best yield. 2 R2NH + 2 AgOAc + CO → [R2N]2CO + 2 HOAc + 2 Ag 3 – 2 - Hydrogenation Silver acetate in a solution of pyridine absorbs hydrogen and is reduced to metallic silver. 3 – 3 - Direct ortho - arylation Silver acetate is a useful reagent for direct ortho-arylation (to install two adjacent substituents on an aromatic ring) for of benzylamines and N-methylbenzylamines. The reaction is palladiumcatalized and requires a slight excess of silver acetate.This reaction is shorter than previous ortho-arylation methods.

Brand name

Smokerette;Tabmint.

World Health Organization (WHO)

Silver acetate has been used as a disinfectant and as an antismoking aid. It was refused registration in Cyprus on the grounds that prolonged use of silver salts can cause permanent argyria and that no well-controlled trials have been performed to establish the safety and efficacy of the preparation. It remains registered as an aid to stopping smoking in Canada and the United States.

General Description

White crystalline plates. Light sensitive. Density 3.26 g / cm3.

Air & Water Reactions

Slightly soluble in water.

Reactivity Profile

Silver acetate is freely soluble in dilute nitric acid [Merck]. Can serve as an oxidizing agent.

Hazard

Toxic material.

Health Hazard

Inhalation of dust irritates nose and throat. Contact with eyes or skin causes irritation. If continued for a long period, ingestion or inhalation of silver compounds can cause permanent discoloration of skin (argyria).

Safety

The LD50 of silver acetate in mice is 36.7 mg/kg. Low doses of silver acetate in mice produced hyper-excitability, ataxia, central nervous system depression, labored breathing, and even death. The U.S. FDA recommends that silver acetate intake be limited to 756 mg over a short period of time; excessive intake may cause argyria.

Synthesis

The silver acetate salt can be synthesized by the reaction of acetic acid and silver carbonate at 45 – 60 °C. After allowing cooling to room temperature, the solid product precipitates. 2 CH3CO2H + Ag2CO3 → 2 AgO2CCH3 + H2O + CO2 It can also be precipitated from concentrated aqueous solutions of silver nitrate by treatment with a solution of sodium acetate. The structure of silver acetate consists of 8-membered Ag2O4C2 rings formed by a pair of acetate ligands bridging a pair of silver centres.

Purification Methods

Shake it with acetic acid for three days, and the process is repeated with fresh acid. The solid is then dried in a vacuum oven at 40o for 48hours. It has also been recrystallised from water containing a trace of acetic acid, and dried in air. Store it in the dark. [Beilstein 2 IV 112.]

Check Digit Verification of cas no

The CAS Registry Mumber 563-63-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,6 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 563-63:
(5*5)+(4*6)+(3*3)+(2*6)+(1*3)=73
73 % 10 = 3
So 563-63-3 is a valid CAS Registry Number.
InChI:InChI=1/C2H4O2.Ag/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1

563-63-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (11660)  Silver acetate, anhydrous, 99%   

  • 563-63-3

  • 25g

  • 1010.0CNY

  • Detail
  • Alfa Aesar

  • (11660)  Silver acetate, anhydrous, 99%   

  • 563-63-3

  • 100g

  • 3027.0CNY

  • Detail
  • Sigma-Aldrich

  • (85140)  Silveracetate  purum p.a., ≥99.0% (T)

  • 563-63-3

  • 85140-10G

  • 1,172.34CNY

  • Detail
  • Sigma-Aldrich

  • (85140)  Silveracetate  purum p.a., ≥99.0% (T)

  • 563-63-3

  • 85140-50G

  • 3,925.35CNY

  • Detail
  • Sigma-Aldrich

  • (216674)  Silveracetate  ReagentPlus®, 99%

  • 563-63-3

  • 216674-5G

  • 480.87CNY

  • Detail
  • Sigma-Aldrich

  • (216674)  Silveracetate  ReagentPlus®, 99%

  • 563-63-3

  • 216674-25G

  • 1,749.15CNY

  • Detail
  • Sigma-Aldrich

  • (216674)  Silveracetate  ReagentPlus®, 99%

  • 563-63-3

  • 216674-100G

  • 4,427.28CNY

  • Detail
  • Aldrich

  • (204374)  Silveracetate  99.99% trace metals basis

  • 563-63-3

  • 204374-10G

  • 1,607.58CNY

  • Detail
  • Aldrich

  • (204374)  Silveracetate  99.99% trace metals basis

  • 563-63-3

  • 204374-50G

  • 5,949.45CNY

  • Detail

563-63-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Silver acetate

1.2 Other means of identification

Product number -
Other names silver,acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:563-63-3 SDS

563-63-3Synthetic route

acetic acid
64-19-7

acetic acid

silver(l) oxide
20667-12-3

silver(l) oxide

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
at 50℃; for 0.0833333h;99%
In acetic acid react. of freshly prepared Ag2O (by electrolysis) with stoichiometric amounts of concd. acid, evapn. until begin of crystn., removal of remaining H2O under diminished pressure; apparatus described;;
In acetic acid crystn. on evapn. of the soln.;;
In acetic acid react. of freshly prepared Ag2O (by electrolysis) with stoichiometric amounts of concd. acid, evapn. until begin of crystn., removal of remaining H2O under diminished pressure; apparatus described;;
sodium acetate
127-09-3

sodium acetate

silver nitrate

silver nitrate

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
With acetic acid In water at 23℃;91%
With acetic acid In water addn. of satd. aq. soln. of sodium acetate to satd. aq. soln. of AgNO3 contg. few drops of acetic acid in the dark; filtration, washing the residue with water, methanol, hexane, drying in vac.;90%
In water soln. of AgNO3 in water was added to soln. of NaCH3CO2 in water; filtered in air, washed with water, EtOH, Et2O, dried in vacuo; elem. anal.;64%
Pd[(μ-O2CMe)2Ag(HO2CMe)2]2
1308661-15-5

Pd[(μ-O2CMe)2Ag(HO2CMe)2]2

1,10-phenanthroline hydrate
5144-89-8

1,10-phenanthroline hydrate

(1,10-phenanthroline)-palladium(II) acetate
35679-81-3

(1,10-phenanthroline)-palladium(II) acetate

B

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
In benzene benzene soln. of ligand added with stirring to benzene soln. of Pd compd. (1:1 molar ratio), mixt. stirred at room temp. for 30 min; ppt. filtered off, concd., pptd. (heptane), dried, elem. anal.;A 75%
B n/a
Pd[(μ-O2CMe)2Ag(HO2CMe)2]2
1308661-15-5

Pd[(μ-O2CMe)2Ag(HO2CMe)2]2

tert-butyl alcohol
75-65-0

tert-butyl alcohol

A

palladium(II) pivalate

palladium(II) pivalate

B

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
In benzene benzene soln. of ligand added with stirring to benzene soln. of Pd compd. (3:1 molar ratio), mixt. stirred at room temp. for 1.5 h; ppt. filtered off, concd., crystd., dried, elem. anal.;A 70%
B n/a
2,4,6-trimethyl-[1,3,5]dioxathiane
53897-55-5

2,4,6-trimethyl-[1,3,5]dioxathiane

moist silver oxide

moist silver oxide

A

silver(I) acetate
563-63-3

silver(I) acetate

B

silver formate

silver formate

C

silver sulfide

silver sulfide

Conditions
ConditionsYield
bei der Oxydation;
LACTIC ACID
849585-22-4

LACTIC ACID

water
7732-18-5

water

Ag2O

Ag2O

A

carbon dioxide
124-38-9

carbon dioxide

B

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
at 100℃;
sodium formate
141-53-7

sodium formate

acetic anhydride
108-24-7

acetic anhydride

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
In acetic anhydride boiling, pptn.;; recrystn. from glacial acetic acid;;
diammine silver(I) acetate

diammine silver(I) acetate

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
With aldehyde In water
With aldehyde In water
diammine silver(I) acetate

diammine silver(I) acetate

A

ammonia
7664-41-7

ammonia

B

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
In water in the air;
In water in the air;
silver perchlorate

silver perchlorate

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
With trimethylamine acetate triacetatesolvate In not given addition of AgClO4 to a solution of the triacetatesolvate of trimethylamine acetate;;
Disilberdiazomethan

Disilberdiazomethan

acetic acid
64-19-7

acetic acid

A

acetic acid methyl ester
79-20-9

acetic acid methyl ester

B

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
In acetic acid in the light within several days;;
Mn(C2H5N3O2)2(CH3COO)2*H2O

Mn(C2H5N3O2)2(CH3COO)2*H2O

silver nitrate

silver nitrate

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
slow react.;
diammine silver(I) acetate

diammine silver(I) acetate

A

silver(I) acetate
563-63-3

silver(I) acetate

B

silver
7440-22-4

silver

Conditions
ConditionsYield
In water aq. soln. of Ag complex dried at 23°C for 24 h; detd. by X-ray diffraction;
potassium acetate
127-08-2

potassium acetate

silver nitrate

silver nitrate

silver(I) acetate
563-63-3

silver(I) acetate

Conditions
ConditionsYield
In water at 20℃;3.1 g
silver(I) acetate
563-63-3

silver(I) acetate

2-<(N-cyclohexyl-N-methylamino)methyl>benzeneselenyl bromide
141819-09-2

2-<(N-cyclohexyl-N-methylamino)methyl>benzeneselenyl bromide

2-(N-cyclohexyl,N-(methylamino)methyl)phenylselenyl acetate

2-(N-cyclohexyl,N-(methylamino)methyl)phenylselenyl acetate

Conditions
ConditionsYield
In dichloromethane for 2h;100%
silver(I) acetate
563-63-3

silver(I) acetate

ethyl 3-bromo-2-oxo-1-azacyclodecane-10-carboxylate

ethyl 3-bromo-2-oxo-1-azacyclodecane-10-carboxylate

(2R,9R)-9-Acetoxy-10-oxo-azecane-2-carboxylic acid ethyl ester

(2R,9R)-9-Acetoxy-10-oxo-azecane-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 100℃; for 3h;100%
silver(I) acetate
563-63-3

silver(I) acetate

4,6-bis(chloromethyl)-2,5-dimethoxytropone
114932-74-0

4,6-bis(chloromethyl)-2,5-dimethoxytropone

4-acetoxymethyl-6-chloromethyl-2,5-dimethoxytropone
114948-32-2

4-acetoxymethyl-6-chloromethyl-2,5-dimethoxytropone

Conditions
ConditionsYield
In acetic acid at 80℃; for 2h;100%
1-chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole
69352-04-1

1-chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole

silver(I) acetate
563-63-3

silver(I) acetate

3,3-dimethyl-1λ3-benzo[d][1,2]iodoxol-1(3H)-yl acetate
175786-58-0

3,3-dimethyl-1λ3-benzo[d][1,2]iodoxol-1(3H)-yl acetate

Conditions
ConditionsYield
In acetonitrile at 20℃; for 15h;100%
In acetonitrile Darkness;98%
97%
silver(I) acetate
563-63-3

silver(I) acetate

11-{[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-Acetoxy-1-(1-bromomethyl-vinyl)-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysene-3a-carbonyl]-amino}-undecanoic acid methyl ester
173106-29-1

11-{[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-Acetoxy-1-(1-bromomethyl-vinyl)-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysene-3a-carbonyl]-amino}-undecanoic acid methyl ester

11-{[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-Acetoxy-1-(1-acetoxymethyl-vinyl)-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysene-3a-carbonyl]-amino}-undecanoic acid methyl ester
150841-09-1

11-{[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bS)-9-Acetoxy-1-(1-acetoxymethyl-vinyl)-5a,5b,8,8,11a-pentamethyl-icosahydro-cyclopenta[a]chrysene-3a-carbonyl]-amino}-undecanoic acid methyl ester

Conditions
ConditionsYield
With tetrabutylammomium bromide In toluene for 2h; Heating;100%
silver(I) acetate
563-63-3

silver(I) acetate

2-<(N-cyclohexyl-N-methylamino)methyl>benzeneselenyl bromide
141819-09-2

2-<(N-cyclohexyl-N-methylamino)methyl>benzeneselenyl bromide

2-[(N-cyclohexyl-N-methylamino)methyl]benzeneselenyl acetate

2-[(N-cyclohexyl-N-methylamino)methyl]benzeneselenyl acetate

Conditions
ConditionsYield
In dichloromethane100%
silver(I) acetate
563-63-3

silver(I) acetate

1-chloro-3,3-bis(trifluoromethyl)-1,3-dihydro-1λ3-benzo[d][1,2]iodaoxole
76215-48-0

1-chloro-3,3-bis(trifluoromethyl)-1,3-dihydro-1λ3-benzo[d][1,2]iodaoxole

3,3-bis(trifluoromethyl)-1λ3 -benzo[d][1,2]iodaoxol-1(3H)-yl acetate

3,3-bis(trifluoromethyl)-1λ3 -benzo[d][1,2]iodaoxol-1(3H)-yl acetate

Conditions
ConditionsYield
In acetonitrile Inert atmosphere; Darkness;100%
In acetonitrile at 20℃; for 14.5h;98%
In acetonitrile at 20℃; Darkness;92%
In acetonitrile at 20℃; for 12h; Darkness;90%
[{trans-Pt(NH3)2Cl}2-μ-spermidine-N1,N8]Cl3

[{trans-Pt(NH3)2Cl}2-μ-spermidine-N1,N8]Cl3

silver(I) acetate
563-63-3

silver(I) acetate

3C2H4O2*C11H35N7O4Pt2

3C2H4O2*C11H35N7O4Pt2

Conditions
ConditionsYield
In water at 40℃; for 24h;100%
di-μ-chlorido-bis(η3-1,3-diphenylallyl)dipalladium(II)

di-μ-chlorido-bis(η3-1,3-diphenylallyl)dipalladium(II)

silver(I) acetate
563-63-3

silver(I) acetate

{(π-PhCHCHCHPh)PdOAc}2

{(π-PhCHCHCHPh)PdOAc}2

Conditions
ConditionsYield
In methanol; dichloromethane silver acetate added to soln. of Pd-compd. at room temp., stirred for 30 min.; filtered, evapd.;100%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

6-([(1R)-endo]-(+)-bornyloxy)-2,2':6',2''-terpyridine

6-([(1R)-endo]-(+)-bornyloxy)-2,2':6',2''-terpyridine

silver(I) acetate
563-63-3

silver(I) acetate

[Ag2(6-([(1R)-endo]-(+)-bornyloxy)-2,2':6',2''-terpyridine)2][PF6]2

[Ag2(6-([(1R)-endo]-(+)-bornyloxy)-2,2':6',2''-terpyridine)2][PF6]2

Conditions
ConditionsYield
In methanol Sonication; mixt. was ultrasonicated for 10 min at room temp.; soln. was filtered and aq. NH4PF6 was added, pptn. was filtered off, washed with water, dried over P2O5; elem. anal.;100%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

6-([(1S)-endo]-(-)-bornyloxy)-2,2':6',2''-terpyridine

6-([(1S)-endo]-(-)-bornyloxy)-2,2':6',2''-terpyridine

silver(I) acetate
563-63-3

silver(I) acetate

[Ag2(6-([(1S)-endo]-(-)-bornyloxy)-2,2':6',2''-terpyridine)2][PF6]2

[Ag2(6-([(1S)-endo]-(-)-bornyloxy)-2,2':6',2''-terpyridine)2][PF6]2

Conditions
ConditionsYield
In methanol Sonication; mixt. was ultrasonicated for 10 min at room temp.; soln. was filtered and aq. NH4PF6 was added, pptn. was filtered off, washed with water, dried over P2O5; elem. anal.;100%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

6-([(1R)-endo]-(+)-bornyloxy)-6''-methyl-2,2':6',2''-terpyridine

6-([(1R)-endo]-(+)-bornyloxy)-6''-methyl-2,2':6',2''-terpyridine

silver(I) acetate
563-63-3

silver(I) acetate

[Ag2(6-([(1R)-endo]-(+)-bornyloxy)-6''-methyl-2,2':6',2''-terpyridine)2][PF6]2

[Ag2(6-([(1R)-endo]-(+)-bornyloxy)-6''-methyl-2,2':6',2''-terpyridine)2][PF6]2

Conditions
ConditionsYield
In methanol Sonication; mixt. was ultrasonicated for 10 min at room temp.; soln. was filtered and aq. NH4PF6 was added, pptn. was filtered off, washed with water, dried over P2O5; elem. anal.;100%
[((C6H4N(2-adamantyl))2C)PdCl2]2

[((C6H4N(2-adamantyl))2C)PdCl2]2

water
7732-18-5

water

silver(I) acetate
563-63-3

silver(I) acetate

[((C6H4N(2-adamantyl))2C)Pd(OH2)(OAc)2]

[((C6H4N(2-adamantyl))2C)Pd(OH2)(OAc)2]

Conditions
ConditionsYield
In dichloromethane (N2); using of Schlenk techniques; combining of 1 equiv. of (((C6H4NC10H15)2C)PdCl2)2 with 4.1 equiv. of AgOAc in wet CH2Cl2; stirring under ambient conditions for 1.5 h; filtration, removal of volatiles in vac.;100%
7,7-dichlorobicyclo<4.1.0>hept-3-ene
6802-78-4, 212268-85-4

7,7-dichlorobicyclo<4.1.0>hept-3-ene

silver(I) acetate
563-63-3

silver(I) acetate

(1α,3β,4β,6α)-4-acetoxy-7,7-dibromobicyclo[4.1.0]heptan-3-ol

(1α,3β,4β,6α)-4-acetoxy-7,7-dibromobicyclo[4.1.0]heptan-3-ol

Conditions
ConditionsYield
Stage #1: 7,7-dichlorobicyclo<4.1.0>hept-3-ene; silver(I) acetate With iodine; acetic acid Inert atmosphere;
Stage #2: With water at 20℃; for 48h; Inert atmosphere;
100%
tributylphosphine
998-40-3

tributylphosphine

silver(I) acetate
563-63-3

silver(I) acetate

tris(tri-n-butyl phosphine)silver(I) acetate

tris(tri-n-butyl phosphine)silver(I) acetate

Conditions
ConditionsYield
In diethyl ether (Ar), Ag acetate suspnd. in Et2O, reacted with 3 equiv. of (n-Bu)3P at 25°C for 1 h under stirring; evapd., elem. anal.;100%
tributylphosphine
998-40-3

tributylphosphine

silver(I) acetate
563-63-3

silver(I) acetate

tetra(tri-n-butyl phosphine)silver(I) acetate
1224594-74-4

tetra(tri-n-butyl phosphine)silver(I) acetate

Conditions
ConditionsYield
In diethyl ether (Ar), Ag acetate suspnd. in Et2O, reacted with 4 equiv. of (n-Bu)3P at 25°C for 1 h under stirring; evapd., elem. anal.;100%
silver(I) acetate
563-63-3

silver(I) acetate

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-4-methyl-6-oxo-6,11-dihydro-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-2-yl acetate
1350539-29-5

11-cyclopropyl-4-methyl-6-oxo-6,11-dihydro-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-2-yl acetate

Conditions
ConditionsYield
With iodine In dichloromethane at 104℃; for 0.0833333h;100%
1-(iodomethyl)-3-(2,2,2-trifluoroacetyl)-2,3-dihydro-1H-benzo[e]indole-7-carbonitrile
1363479-47-3

1-(iodomethyl)-3-(2,2,2-trifluoroacetyl)-2,3-dihydro-1H-benzo[e]indole-7-carbonitrile

silver(I) acetate
563-63-3

silver(I) acetate

(7-cyano-3-(2,2,2-trifluoroacetyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)methyl acetate
1363479-50-8

(7-cyano-3-(2,2,2-trifluoroacetyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)methyl acetate

Conditions
ConditionsYield
In acetic acid for 48h; Reflux;100%
5,10,15,20-tetratolyl-2-aza-21-diphenylphosphoryl-21-carbaporphyrin

5,10,15,20-tetratolyl-2-aza-21-diphenylphosphoryl-21-carbaporphyrin

silver(I) acetate
563-63-3

silver(I) acetate

C48H36AgN4

C48H36AgN4

Conditions
ConditionsYield
In chloroform; acetonitrile100%
5,10,15,20-tetratolyl-2-aza-3-diphenylophosphoryl-21-carbaporphyrin

5,10,15,20-tetratolyl-2-aza-3-diphenylophosphoryl-21-carbaporphyrin

silver(I) acetate
563-63-3

silver(I) acetate

silver(III) 5,10,15,20-tetratolyl-2-aza-3-diphenylphosphoryl-21-carbaporphiryn

silver(III) 5,10,15,20-tetratolyl-2-aza-3-diphenylphosphoryl-21-carbaporphiryn

Conditions
ConditionsYield
In dichloromethane; acetonitrile at 20℃; for 1h;100%
C38H48Cl2N6NiO2Pd

C38H48Cl2N6NiO2Pd

silver(I) acetate
563-63-3

silver(I) acetate

C42H54N6NiO6Pd

C42H54N6NiO6Pd

Conditions
ConditionsYield
In dichloromethane at 20℃; for 0.333333h; Inert atmosphere; Optical yield = 54.545 %de;100%
trans-1,2-dimethylcyclopentane
13012-46-9

trans-1,2-dimethylcyclopentane

C40H76N2O2(2+)*2NO3(1-)

C40H76N2O2(2+)*2NO3(1-)

silver(I) acetate
563-63-3

silver(I) acetate

C87H161CoN6O4(4+)*4NO3(1-)

C87H161CoN6O4(4+)*4NO3(1-)

Conditions
ConditionsYield
Stage #1: trans-1,2-dimethylcyclopentane; C40H76N2O2(2+)*2NO3(1-) In dichloromethane at 20℃;
Stage #2: cobalt(II) acetate In dichloromethane at 20℃; for 12h;
Stage #3: silver(I) acetate In dichloromethane for 12h;
100%
2,2-Dimethyl-1,3-diaminopropane
7328-91-8

2,2-Dimethyl-1,3-diaminopropane

C40H76N2O2(2+)*2NO3(1-)

C40H76N2O2(2+)*2NO3(1-)

silver(I) acetate
563-63-3

silver(I) acetate

C87H163CoN6O4(4+)*4NO3(1-)

C87H163CoN6O4(4+)*4NO3(1-)

Conditions
ConditionsYield
Stage #1: 2,2-Dimethyl-1,3-diaminopropane; C40H76N2O2(2+)*2NO3(1-) In dichloromethane at 20℃;
Stage #2: cobalt(II) acetate In dichloromethane at 20℃; for 12h;
Stage #3: silver(I) acetate In dichloromethane for 12h;
100%
C32H43BrP2Pd

C32H43BrP2Pd

silver(I) acetate
563-63-3

silver(I) acetate

C34H46O2P2Pd

C34H46O2P2Pd

Conditions
ConditionsYield
In toluene at 25℃; for 2h; Glovebox;100%
trans-1,2-diaminocyclohexane monohydrochloride

trans-1,2-diaminocyclohexane monohydrochloride

{3-methyl-5-[{Bu3N+(CH2)3}2CMe]salicylaldehyde}(I-)2

{3-methyl-5-[{Bu3N+(CH2)3}2CMe]salicylaldehyde}(I-)2

silver(I) acetate
563-63-3

silver(I) acetate

silver nitrate

silver nitrate

C56H95CoN4O5(2+)*2NO3(1-)

C56H95CoN4O5(2+)*2NO3(1-)

Conditions
ConditionsYield
Stage #1: trans-1,2-diaminocyclohexane monohydrochloride; {3-methyl-5-[{Bu3N+(CH2)3}2CMe]salicylaldehyde}(I-)2 With sodium t-butanolate In methanol for 4h; Inert atmosphere;
Stage #2: silver nitrate In dichloromethane for 5h; Darkness;
Stage #3: silver(I) acetate; cobalt(II) acetate Further stages;
100%
C22H20N(1+)*I(1-)

C22H20N(1+)*I(1-)

silver(I) acetate
563-63-3

silver(I) acetate

C22H20N(1+)*C2H3O2(1-)

C22H20N(1+)*C2H3O2(1-)

Conditions
ConditionsYield
In methanol for 0.333333h;100%
C22H20N(1+)*Br(1-)

C22H20N(1+)*Br(1-)

silver(I) acetate
563-63-3

silver(I) acetate

C22H20N(1+)*C2H3O2(1-)

C22H20N(1+)*C2H3O2(1-)

Conditions
ConditionsYield
In methanol for 0.333333h;100%
tert-butylisonitrile
119072-55-8, 7188-38-7

tert-butylisonitrile

silver(I) acetate
563-63-3

silver(I) acetate

C5H9N*Ag(1+)*C2H3O2(1-)

C5H9N*Ag(1+)*C2H3O2(1-)

Conditions
ConditionsYield
In dichloromethane at 20℃; for 1h; Inert atmosphere;100%
sodium hexaflorophosphate

sodium hexaflorophosphate

C48H46N4

C48H46N4

silver(I) acetate
563-63-3

silver(I) acetate

C48H46N4*Ag(1+)*F6P(1-)

C48H46N4*Ag(1+)*F6P(1-)

Conditions
ConditionsYield
Stage #1: C48H46N4; silver(I) acetate In methanol
Stage #2: sodium hexaflorophosphate
100%
8-amino quinoline
578-66-5

8-amino quinoline

silver(I) acetate
563-63-3

silver(I) acetate

N-(quinolin-8-yl)acetamide
33757-42-5

N-(quinolin-8-yl)acetamide

Conditions
ConditionsYield
With nickel(II) triflate In chlorobenzene at 140℃; for 24h;100%

563-63-3Relevant articles and documents

Reactive silver inks for patterning high-conductivity features at mild temperatures

Walker, S. Brett,Lewis, Jennifer A.

, p. 1419 - 1421 (2012)

Reactive silver inks for printing highly conductive features (>10 4 S/cm) at room temperature have been created. These inks are stable, particle-free, and suitable for a wide range of patterning techniques. Upon annealing at 90 °C, the printed electrodes exhibit an electrical conductivity equivalent to that of bulk silver.

Boulin, D.,Ellis, W. C.

, p. 290 - 292 (1970)

Hubieki, W.,Wiacek, K.

, p. 97 - 103 (1960)

Free Amino Group-Directed γ-C(sp3)-H Arylation of α-Amino Esters with Diaryliodonium Triflates by Palladium Catalysis

Pramanick, Pranab K.,Zhou, Zhibing,Hou, Zhen-Lin,Yao, Bo

, (2019)

Free amino group-directed C(sp3)-H functionalization of aliphatic amines is a fundamental challenge in synthetic organic chemistry. Also, the NH2-directed C(sp3)-H functionalization of α-amino acids and their derivatives remains barely explored. With palladium as the catalyst and Ag2O as the additive, we developed the first NH2-directed γ-C(sp3)-H arylation of α-amino esters with diaryliodonium triflates for the construction of synthetically useful γ-aryl-α-amino esters, and the result of the KIE study suggested that the catalytic reaction involved an irreversible C-H cleavage as the rate-determining step.

New antitumour active platinum compounds containing carboxylate ligands in trans geometry: Synthesis, crystal structure and biological activity

Van Zutphen, Steven,Pantoja, Elena,Soriano, Rosario,Soro, Carlos,Tooke, Duncan M.,Spek, Anthony L.,Den Dulk, Hans,Brouwer, Jaap,Reedijk, Jan

, p. 1020 - 1023 (2006)

New asymmetric trans-platinum(ii) complexes, composed of an isopropylamine, an azole and two carboxylate leaving groups, are presented. The crystal and molecular structures of one of the complexes has been determined and the cytotoxicity and reactivity with 5′-guanosine monophosphate is reported. The complexes show a reduced reactivity, but no decrease in cytotoxic activity compared to their chloro-counterparts. Furthermore the complexes largely overcome cisplatin resistance, they therefore present an interesting class of antitumour active trans-platinum complexes. The Royal Society of Chemistry 2006.

MANUFACTURING METHOD OF FLUORINATED HYDROCARBON

-

Paragraph 0059, (2018/05/08)

PROBLEM TO BE SOLVED: To provide a method for industrially advantageously manufacturing fluorinated hydrocarbon (3). SOLUTION: There is provided a method for manufacturing fluorinated hydrocarbon represented by the formula (3), including contacting a secondary or tertiary ether compound represented by the formula (1) and acid fluoride represented by the formula (2) in the presence of a silver salt in a hydrocarbon solvent. R1 and R2 are each independently a C1 to 3 alkyl group, R1 and R2 may bind to form a ring structure, R3 is H, a methyl group or an ethyl group, R4 and R5 are each independently a methyl group or an ethyl group. SELECTED DRAWING: None COPYRIGHT: (C)2018,JPOandINPIT

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 563-63-3